RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: acute kidney failure
Accession: DOID:3021
browse the term
Definition: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
Synonyms: exact_synonym: Acute Kidney Failures; Acute Kidney Injuries; Acute Kidney Injury; Acute Kidney Insufficiencies; Acute Kidney Insufficiency; Acute Renal Failure; Acute Renal Failures; Acute Renal Injuries; Acute Renal Injury; Acute Renal Insufficiencies; Acute Renal Insufficiency
narrow_synonym: post-operative acute kidney injury; postoperative acute kidney injury
primary_id: MESH:D058186 ; RDO:0001702
xref: EFO:0009955
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:24502693
RGD:11039053
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
ADRB2
adrenoceptor beta 2
treatment
ISO
associated with endotoxemia; protein:increased expression:kidney associated with Bacteremia; associated with Endotoxemia;
RGD
PMID:14747378 PMID:19020966 PMID:19887504
RGD:7175276 RGD:7175281 RGD:7175283
NCBI chr 5:144,259,756...144,398,421
Ensembl chr 5:150,267,554...150,315,892
G
AFM
afamin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 4:50,691,556...50,714,140
Ensembl chr 4:56,519,389...56,545,974
G
AGER
advanced glycosylation end-product specific receptor
ISO
RGD
PMID:21811803
RGD:7243868
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
AHSG
alpha 2-HS glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:183,644,223...183,652,620
Ensembl chr 3:192,110,770...192,119,915
G
ALAD
aminolevulinate dehydratase
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:19484701
RGD:4144146
NCBI chr 9:84,488,339...84,503,360
Ensembl chr 9:112,859,171...112,873,784
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:2048579 PMID:21259293 PMID:24361871 PMID:28885000
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
ALOX5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:19194548
RGD:2317536
NCBI chr10:42,461,398...42,531,576
Ensembl chr10:45,639,946...45,710,016
G
AMBP
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:8963945 PMID:28885000
RGD:6904218
NCBI chr 9:85,157,680...85,176,253
Ensembl chr 9:113,525,835...113,543,422
G
AMN
amnion associated transmembrane protein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20514524
NCBI chr14:83,541,891...83,550,346
Ensembl chr14:103,356,773...103,365,352
G
ANXA1
annexin A1
treatment
ISO
RGD
PMID:22101490
RGD:7421583
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
AR
androgen receptor
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr X:56,722,828...56,909,004
Ensembl chr X:66,791,081...66,969,357
G
ARG1
arginase 1
ISO
mRNA:decreased expression:renal tubule (rat)
RGD
PMID:12371970
RGD:631989
NCBI chr 6:129,372,747...129,383,880
Ensembl chr 6:133,479,966...133,491,162
G
ARG2
arginase 2
ISO
mRNA:decreased expression:renal tubule (rat)
RGD
PMID:12371970
RGD:631989
NCBI chr14:48,197,831...48,231,829
Ensembl chr14:67,075,941...67,109,962
G
ATP5F1B
ATP synthase F1 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25666834
NCBI chr12:32,264,570...32,272,419
Ensembl chr12:32,519,749...32,527,753
G
AVP
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2139164
NCBI chr20:3,169,094...3,172,900
G
AVPR1A
arginine vasopressin receptor 1A
ISO
RGD
PMID:17347933
RGD:2300348
NCBI chr12:25,793,633...25,803,026
Ensembl chr12:26,065,882...26,075,972
G
B2M
beta-2-microglobulin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:2689182 PMID:19536607 PMID:22005293 PMID:28885000
RGD:6482685
NCBI chr15:23,668,108...23,674,791
Ensembl chr15:41,836,345...41,842,991
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:20037173
RGD:10053672
NCBI chr11:59,626,981...59,641,824
Ensembl chr11:62,971,808...62,986,257
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20037173 PMID:20623750
RGD:10053672
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
BCL2
BCL2 apoptosis regulator
ISO
protein:increased expression:kidney
RGD
PMID:20037173
RGD:10053672
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
BCL2L1
BCL2 like 1
ISO
protein:increased expression:kidney
RGD
PMID:20037173
RGD:10053672
NCBI chr20:27,955,688...28,015,950
Ensembl chr20:29,088,055...29,146,585
G
BDKRB2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24975837
NCBI chr14:76,832,833...76,873,860
Ensembl chr14:96,156,494...96,196,253
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CAPN1
calpain 1
treatment
ISO
associated with Rhabdomyolysis;
RGD
PMID:24158126
RGD:13792553
NCBI chr11:60,545,837...60,576,631
Ensembl chr11:63,886,015...63,916,021
G
CASP1
caspase 1
ISO
RGD
PMID:16557226
RGD:2293624
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
G
CCL5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:serum (mouse)
RGD
PMID:19508392
RGD:4889990
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CCR5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26055553
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CCT7
chaperonin containing TCP1 subunit 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31825490
NCBI chr2A:73,287,026...73,305,792
Ensembl chr2A:74,775,781...74,794,515
G
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr11:35,110,732...35,258,238
Ensembl chr11:34,985,634...35,079,009
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:kidney
RGD
PMID:16557226
RGD:2293624
NCBI chr12:12,742,258...12,747,404
Ensembl chr12:13,120,306...13,125,541
G
CLU
clusterin
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:urine
CTD RGD
PMID:20118187 PMID:20623750 PMID:22005293 PMID:22581811 PMID:23052191 PMID:24361871 PMID:28885000 More...
RGD:7245501
NCBI chr 8:26,867,973...26,884,838
Ensembl chr 8:24,070,053...24,083,523
G
CP
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:146,180,527...146,239,833
Ensembl chr 3:153,764,830...153,817,544
G
CRP
C-reactive protein
ISO
protein:increased expression:serum associated with Myocardial Infarction;
RGD
PMID:22551254 PMID:22694718
RGD:6903282 RGD:6906888
NCBI chr 1:135,062,102...135,064,402
G
CSF1
colony stimulating factor 1
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr 1:112,555,755...112,575,894
Ensembl chr 1:127,764,916...127,781,943
G
CSF1R
colony stimulating factor 1 receptor
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr 5:145,478,725...145,537,858
Ensembl chr 5:151,483,572...151,517,415
G
CST3
cystatin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22005293 PMID:28885000
NCBI chr20:23,583,043...23,587,399
Ensembl chr20:23,935,942...23,940,425
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
treatment
ISO
RGD
PMID:18495746 PMID:19890363
RGD:7257732 RGD:7257735
NCBI chr15:53,664,968...53,672,277
Ensembl chr15:73,284,566...73,290,636
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
treatment
ISO
RGD
PMID:18495746 PMID:23981375
RGD:7257727 RGD:7257735
NCBI chr15:53,692,877...53,699,279
Ensembl chr15:73,311,720...73,319,447
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
RGD
PMID:6223803
RGD:2307326
NCBI chr12:31,158,814...31,164,462
Ensembl chr12:31,419,773...31,424,822
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr10:91,375,255...91,465,215
Ensembl chr10:94,884,472...94,970,065
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr10:91,547,865...91,598,918
Ensembl chr10:95,022,482...95,105,653
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
ISO
RGD
PMID:24412858 PMID:24717297
RGD:14700914 RGD:14700920
Ensembl chr10:134,839,025...134,852,719
G
DDIT3
DNA damage inducible transcript 3
ISO
Protein:increased expression:renal tubule epithelium
RGD
PMID:15476864
RGD:1599736
NCBI chr12:31,406,332...31,410,293
Ensembl chr12:31,664,743...31,668,701
G
DLL4
delta like canonical Notch ligand 4
ameliorates
ISO
RGD
PMID:19828677
RGD:155663373
NCBI chr15:19,871,584...19,881,817
Ensembl chr15:38,121,574...38,129,471
G
ECE1
endothelin converting enzyme 1
ISO
RGD
PMID:10073607 PMID:11043448
RGD:7244180 RGD:7244185
NCBI chr 1:20,166,019...20,290,803
Ensembl chr 1:21,206,199...21,278,909
G
EDN1
endothelin 1
ISO
mRNA, protein:increased expression:kidney (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9788586 PMID:19967049
RGD:4144852
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
G
EGF
epidermal growth factor
ISO
mRNA:decreased expression:kidney
RGD
PMID:11340354 PMID:20482449
RGD:10395241 RGD:6906908
NCBI chr 4:102,410,724...102,509,691
Ensembl chr 4:112,977,565...113,076,460
G
EGFR
epidermal growth factor receptor
ISO
mRNA:increased expression:kidney CTD Direct Evidence: therapeutic
RGD CTD
PMID:11340354 PMID:14638913
RGD:10395241
NCBI chr 7:55,614,042...55,807,285
Ensembl chr 7:56,046,296...56,111,615
G
EGLN1
egl-9 family hypoxia inducible factor 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 1:206,915,541...206,976,656
G
EGLN3
egl-9 family hypoxia inducible factor 3
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr14:14,689,398...14,716,301
Ensembl chr14:32,880,324...32,907,241
G
EPAS1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:16762988
RGD:10395386
NCBI chr2A:46,403,411...46,492,734
Ensembl chr2A:47,332,308...47,421,560
G
EPHX2
epoxide hydrolase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26165641
NCBI chr 8:26,761,090...26,818,436
Ensembl chr 8:23,964,094...24,017,749
G
EPO
erythropoietin
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21847101 PMID:22209169 PMID:22235348 PMID:24561306
RGD:10400913 RGD:11041660
NCBI chr 7:92,747,671...92,750,886
Ensembl chr 7:106,148,062...106,150,974
G
FAS
Fas cell surface death receptor
ISO
protein:increased expression:renal tubule (rat)
RGD
PMID:21374789
RGD:8663469
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FGA
fibrinogen alpha chain
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:15805072
RGD:9685024
NCBI chr 4:146,949,680...146,957,291
G
FIS1
fission, mitochondrial 1
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:26480480
RGD:12910862
NCBI chr 7:93,381,058...93,386,483
Ensembl chr 7:106,621,211...106,626,683
G
FN1
fibronectin 1
ISO
protein:increased expression:kidney
RGD
PMID:11768240 PMID:12884040
RGD:7205684 RGD:729934
NCBI chr2B:102,623,568...102,698,747
Ensembl chr2B:221,208,431...221,284,003
G
FSTL1
follistatin like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20861081
NCBI chr 3:117,508,772...117,564,254
Ensembl chr 3:124,422,968...124,475,431
G
G6PD
glucose-6-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:602954 PMID:734759 PMID:4794122
NCBI chr X:143,972,798...143,988,960
Ensembl chr X:153,843,092...153,860,674
G
GAS6
growth arrest specific 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19564549
Ensembl chr13:113,968,843...114,009,562
G
GATM
glycine amidinotransferase
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:2752493
RGD:1599823
NCBI chr15:24,309,045...24,326,673
Ensembl chr15:42,639,597...42,657,209
G
GC
GC vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 4:52,431,196...52,473,762
Ensembl chr 4:58,729,236...58,792,073
G
GFER
growth factor, augmenter of liver regeneration
treatment
ISO
CTD Direct Evidence: therapeutic protein:increased expression:cortex of kidney,renal medulla:
RGD CTD
PMID:20030531
RGD:9685736
NCBI chr16:716,640...720,196
Ensembl chr16:2,073,064...2,076,592
G
GHRL
ghrelin and obestatin prepropeptide
ISO
RGD
PMID:19625378
RGD:7242430
NCBI chr 3:10,221,829...10,229,229
Ensembl chr 3:10,573,537...10,580,723
G
GOT2
glutamic-oxaloacetic transaminase 2
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:23924727
RGD:13506245
NCBI chr16:38,995,770...39,022,750
Ensembl chr16:58,120,781...58,147,378
G
GPNMB
glycoprotein nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr 7:23,931,220...23,959,687
Ensembl chr 7:23,539,928...23,568,624
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:22209169
RGD:10400913
Ensembl chr 8:144,259,991...144,263,737
G
GPX3
glutathione peroxidase 3
ISO
protein:decreased expression:kidney
RGD
PMID:36583727
RGD:401827125
NCBI chr 5:146,447,939...146,456,476
G
GPX4
glutathione peroxidase 4
treatment
ISO
RGD
PMID:29548851
RGD:401827911
NCBI chr19:20,904...23,828
G
GSK3B
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22785175
NCBI chr 3:116,943,205...117,215,001
Ensembl chr 3:123,861,379...124,126,771
G
GSR
glutathione-disulfide reductase
ISO
protein:decreased activity:kidney: glycerol-induced
RGD
PMID:1870354 PMID:22286819
RGD:7257559 RGD:7257585
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
GSTM2
glutathione S-transferase mu 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:112,043,201...112,050,810
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:20798258
RGD:6903954
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:urine: CTD Direct Evidence: marker/mechanism associated with Pyelonephritis;protein:increased expression:urine:
RGD CTD
PMID:20118187 PMID:21259293 PMID:21835770 PMID:22005293 PMID:23019274 PMID:23052191 PMID:23319831 PMID:23683031 PMID:23845967 PMID:24189134 PMID:24361871 PMID:24958931 PMID:28885000 More...
RGD:7244370 RGD:7245472 RGD:7245495
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
HBEGF
heparin binding EGF like growth factor
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:kidney
CTD RGD
PMID:7635938 PMID:11340354
RGD:10395241
NCBI chr 5:135,699,553...135,713,366
Ensembl chr 5:141,816,402...141,830,531
G
HDAC2
histone deacetylase 2
treatment
ISO
associated with sepsis;
RGD
PMID:22933299
RGD:9590257
NCBI chr 6:111,731,139...111,761,826
Ensembl chr 6:115,802,367...115,833,004
G
HDAC3
histone deacetylase 3
ISO
RGD
PMID:21416250
RGD:10047111
NCBI chr 5:136,981,790...136,997,786
Ensembl chr 5:143,094,406...143,110,322
G
HDAC5
histone deacetylase 5
treatment
ISO
associated with sepsis;
RGD
PMID:21416250 PMID:22933299
RGD:10047111 RGD:9590257
NCBI chr17:13,273,052...13,319,695
Ensembl chr17:13,446,836...13,479,140
G
HES1
hes family bHLH transcription factor 1
ISO
mRNA:increased expression:kidney collecting duct (rat) protein:increased expression:kidney tubule (rat)
RGD
PMID:24325066 PMID:24397211
RGD:9685383 RGD:9685389
NCBI chr 3:191,432,513...191,435,387
Ensembl chr 3:201,749,044...201,754,257
G
HEXB
hexosaminidase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22005293
NCBI chr 5:40,589,448...40,625,176
Ensembl chr 5:41,199,681...41,232,693
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment
ISO
mRNA:increased expression:renal cortex (rat)
RGD
PMID:15673301 PMID:16762988 PMID:18593636
RGD:10395376 RGD:10395386 RGD:9068894
NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885
G
HIPK1
homeodomain interacting protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36052886
NCBI chr 1:88,579,603...88,627,988
Ensembl chr 1:123,633,134...123,677,714
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
associated with Sepsis
RGD
PMID:16557230
RGD:5508471
NCBI chr 5:39,936,630...39,961,519
Ensembl chr 5:40,548,919...40,573,785
G
HMOX1
heme oxygenase 1
treatment
ISO
associated with Sepsis CTD Direct Evidence: therapeutic
RGD CTD
PMID:21048024 PMID:23807243
RGD:10755583
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
HPX
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr11:6,558,279...6,572,946
Ensembl chr11:6,246,392...6,256,410
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12690470 PMID:19546256
NCBI chr 6:31,476,710...31,491,411
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein:increased expression:kidney, lysosome (rat)
RGD
PMID:14966137
RGD:7242786
NCBI chr11:117,890,545...117,895,262
Ensembl chr11:121,809,800...121,815,773
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:22659586
RGD:7175102
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7540432
NCBI chr12:99,986,887...100,066,773
Ensembl chr12:103,385,911...103,462,177
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA: decreased expression: kidney: both cortex and medulla
RGD
PMID:9767523
RGD:7242908
NCBI chr15:77,332,926...77,648,474
Ensembl chr15:96,535,164...96,832,974
G
IGFBP1
insulin like growth factor binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7540432
NCBI chr 7:46,538,566...46,545,536
Ensembl chr 7:46,658,097...46,662,584
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18460982
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
ISO
RGD
PMID:11342578
RGD:6893450
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1A
interleukin 1 alpha
ISO
RGD
PMID:21716595
RGD:6907069
NCBI chr2A:89,273,482...89,284,421
Ensembl chr2A:113,784,854...113,795,801
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:kidney (rat) mRNA:increased expression:kidney, liver, spleen (mouse)
RGD
PMID:21677145 PMID:22286667 PMID:22659586 PMID:22750969
RGD:7175094 RGD:7175102 RGD:7175258 RGD:7175314
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL1RN
interleukin 1 receptor antagonist
ISO
associated with Asphyxia; rat model treated with human protein associated with Sepsis
RGD
PMID:14610321 PMID:16259926 PMID:16763508
RGD:6907360 RGD:6907369 RGD:6907375
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL20
interleukin 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18496552
NCBI chr 1:182,468,571...182,472,440
Ensembl chr 1:186,747,086...186,750,952
G
IL6
interleukin 6
ISO
associated with Acute Lung Injury;protein:increased expression:plasma CTD Direct Evidence: therapeutic
RGD CTD
PMID:18074478 PMID:21570986
RGD:5128661
NCBI chr 7:23,415,922...23,420,767
G
INS
insulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12243603
NCBI chr11:2,200,785...2,202,579
Ensembl chr11:2,218,117...2,231,666
G
JAK2
Janus kinase 2
treatment
ISO
associated with Carcinoma, Lewis Lung, human cells in mouse model
RGD
PMID:31250048
RGD:149735351
NCBI chr 9:4,820,303...4,971,867
Ensembl chr 9:5,006,271...5,156,626
G
KLK1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18227104
NCBI chr19:47,784,368...47,789,004
Ensembl chr19:56,677,579...56,682,216
G
KNG1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:513486 PMID:3015452
NCBI chr 3:183,751,598...183,778,655
Ensembl chr 3:192,219,462...192,245,149
G
LCN2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:urine associated with open cardiac surgeries;protein:increased expression:urine:
CTD RGD
PMID:20623750 PMID:22005293 PMID:23052191 PMID:23336369 PMID:23683031 PMID:27888128 PMID:28411423 PMID:28885000 More...
RGD:125973912 RGD:126781714 RGD:7244370
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
G
LGALS3
galectin 3
ISO
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr14:35,715,850...35,732,263
Ensembl chr14:53,990,023...54,006,412
G
LOC100972354
interferon alpha-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12810204
NCBI chr 9:21,245,017...21,246,210
Ensembl chr 9:21,863,062...21,863,736
G
LOC100976904
growth-regulated alpha protein
ISO
mRNA:increased expression:kidney, liver, spleen
RGD
PMID:21677145
RGD:7175314
NCBI chr 4:50,325,248...50,327,165
Ensembl chr 4:56,153,899...56,159,474
G
LOC100979149
hemoglobin subunit gamma-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:562503 PMID:851170
NCBI chr11:5,402,198...5,407,442
G
LOC100979269
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr12:9,154,457...9,202,833
Ensembl chr12:9,385,359...9,433,979
G
LOC100980965
zinc-alpha-2-glycoprotein
disease_progression
ISO
RGD
PMID:23849457
RGD:153350150
NCBI chr 7:91,999,717...92,009,066
Ensembl chr 7:105,432,782...105,442,219
G
LOC100982214
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 6:158,662,192...158,713,413
Ensembl chr 6:163,673,464...163,736,777
G
LOC100988273
cytochrome P450 2D6-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr22:23,022,449...23,031,627
G
LRG1
leucine rich alpha-2-glycoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34677723
NCBI chr19:3,557,079...3,560,193
Ensembl chr19:4,504,704...4,507,790
G
LRP2
LDL receptor related protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29286200
NCBI chr2B:56,407,871...56,640,471
Ensembl chr2B:173,873,767...174,103,697
G
MB
myoglobin
ISO
protein: increased expression: serum
RGD
PMID:9822635 PMID:23497406
RGD:7244253 RGD:7244259
NCBI chr22:16,612,519...16,645,333
Ensembl chr22:34,452,451...34,463,224
G
MET
MET proto-oncogene, receptor tyrosine kinase
ISO
protein:increased expression:renal parenchyma (rat)
RGD
PMID:17940345
RGD:2317469
NCBI chr 7:108,646,278...108,772,238
Ensembl chr 7:121,365,438...121,468,159
G
MFN1
mitofusin 1
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:26480480
RGD:12910862
NCBI chr 3:176,378,175...176,423,943
Ensembl chr 3:184,552,108...184,596,763
G
MPO
myeloperoxidase
ISO
DNA:haplotye: : CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19793022 PMID:20623750 PMID:22739978
RGD:6909168 RGD:6909185
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
G
MTHFR
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17387702
NCBI chr 1:10,548,196...10,568,174
Ensembl chr 1:11,766,334...11,785,419
G
MTOR
mechanistic target of rapamycin kinase
ISO
RGD
PMID:23022334
RGD:7245507
NCBI chr 1:9,871,700...10,028,704
Ensembl chr 1:11,093,765...11,249,841
G
MYC
MYC proto-oncogene, bHLH transcription factor
susceptibility
ISO
protein:decreased phosphorylation:kidney (mouse)
RGD
PMID:23228991
RGD:7207407
NCBI chr 8:124,387,561...124,393,551
Ensembl chr 8:127,131,512...127,136,863
G
NDUFB8
NADH:ubiquinone oxidoreductase subunit B8
ISO
RGD
PMID:22160772
RGD:13801199
NCBI chr10:97,123,826...97,129,919
Ensembl chr10:100,604,914...100,611,016
G
NES
nestin
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr 1:132,012,273...132,020,907
Ensembl chr 1:135,835,456...135,844,094
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:24291173 PMID:24958931
RGD:10412697
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NFKB1
nuclear factor kappa B subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29286200
NCBI chr 4:94,925,048...95,040,849
Ensembl chr 4:105,589,062...105,704,098
G
NOS1
nitric oxide synthase 1
ISO
RGD
PMID:14531809
RGD:13825139
NCBI chr12:114,784,232...114,938,385
Ensembl chr12:118,163,655...118,314,005
G
NOS2
nitric oxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9810145
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NOS3
nitric oxide synthase 3
ISO
CTD Direct Evidence: marker/mechanism in females;mRNA:increased expression:cortex of kidney (rat)
CTD RGD
PMID:9788586 PMID:28947737
RGD:13450947
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
NPPA
natriuretic peptide A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:kidney
CTD RGD
PMID:1825077 PMID:2948068 PMID:19298916 PMID:22209992
RGD:7247715
NCBI chr 1:10,608,025...10,610,287
Ensembl chr 1:11,825,072...11,827,373
G
NPPB
natriuretic peptide B
ISO
mRNA:increased expression:kidney associated with Myocardial Infarction;protein:increased expression:serum: associated with lung diseases;protein:increased expression:serum: associated with Pneumonia;protein:increased expression:serum:
RGD
PMID:22209992 PMID:23192919 PMID:23415693 PMID:23837838
RGD:7247620 RGD:7247622 RGD:7247624 RGD:7247715
NCBI chr 1:10,621,416...10,622,960
Ensembl chr 1:11,838,518...11,839,995
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:26723870 PMID:28230744
RGD:13440091
NCBI chr16:50,090,696...50,106,495
Ensembl chr16:69,470,288...69,489,731
G
OCLN
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19766176
NCBI chr 5:44,447,230...44,509,637
Ensembl chr 5:46,023,437...46,069,342
G
ORM1
orosomucoid 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 9:85,421,254...85,424,659
G
PARP1
poly(ADP-ribose) polymerase 1
ISO
RGD
PMID:21884784
RGD:5510015
NCBI chr 1:201,820,355...201,867,673
Ensembl chr 1:206,812,981...206,860,356
G
PKD2
polycystin 2, transient receptor potential cation channel
ISO
protein:altered localization
RGD
PMID:12089381
RGD:7175293
NCBI chr 4:80,295,243...80,365,271
Ensembl chr 4:91,019,734...91,086,775
G
PLAT
plasminogen activator, tissue type
ISO
protein:increased expression:plasma (human)
RGD
PMID:9767551
RGD:11541071
NCBI chr 8:41,419,415...41,451,951
Ensembl chr 8:38,864,918...38,897,779
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17216604
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
G
PPARG
peroxisome proliferator activated receptor gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:17494862 PMID:20623750 PMID:24011919 PMID:24433871
RGD:8553020
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
associated with Endotoxemia
RGD
PMID:21881206
RGD:7242026
NCBI chr 4:18,196,431...18,876,889
Ensembl chr 4:23,483,377...23,581,212
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
treatment
ISO
RGD
PMID:19092124
RGD:11250410
NCBI chr2B:32,846,899...32,859,060
Ensembl chr2B:128,083,794...128,094,625
G
PROCR
protein C receptor
treatment
ISO
associated with Sepsis
RGD
PMID:23807243
RGD:10755583
NCBI chr20:31,500,838...31,543,928
Ensembl chr20:32,622,876...32,628,320
G
PTAFR
platelet activating factor receptor
treatment
ISO
associated with Endotoxemia
RGD
PMID:2538527
RGD:10043182
NCBI chr 1:27,405,880...27,436,184
Ensembl chr 1:28,447,833...28,448,861
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:16871242
RGD:10003092
NCBI chr 5:69,686,906...69,700,739
Ensembl chr 5:74,731,470...74,745,148
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21893983
RGD:5508181
NCBI chr 1:162,205,534...162,214,130
Ensembl chr 1:166,355,845...166,364,519
G
RAPGEF3
Rap guanine nucleotide exchange factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21745194
NCBI chr12:40,974,756...40,999,471
Ensembl chr12:41,848,785...41,873,252
G
RB1
RB transcriptional corepressor 1
ISO
associated with Sepsis;protein:increased phosphorylation:kidney
RGD
PMID:19428114
RGD:8547990
NCBI chr13:29,453,872...29,624,665
Ensembl chr13:48,155,795...48,324,575
G
REN
renin
exacerbates
ISO
Associated with toxic shock syndrome;protein:increased expression:blood plasma (human)
RGD
PMID:30407370
RGD:125097506
NCBI chr 1:179,757,653...179,769,530
Ensembl chr 1:184,046,117...184,057,393
G
SCGB1A1
secretoglobin family 1A member 1
ISO
associated with LPS induced endotoxemia
RGD
PMID:18824919
RGD:2313129
NCBI chr11:57,774,560...57,780,334
Ensembl chr11:61,133,649...61,137,873
G
SERPINA1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr14:75,001,714...75,014,214
Ensembl chr14:94,334,258...94,345,419
G
SERPINC1
serpin family C member 1
ISO
associated with heart failure; protein:decreased activity:plasma:
RGD
PMID:26108065
RGD:11354006
NCBI chr 1:149,421,737...149,435,301
Ensembl chr 1:153,126,031...153,139,369
G
SIRT1
sirtuin 1
severity
ISO
protein:increased expression:kidney (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21416250
RGD:10047111
NCBI chr10:64,368,878...64,401,684
Ensembl chr10:66,681,598...66,715,069
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941
G
SLC22A1
solute carrier family 22 member 1
treatment
ISO
RGD
PMID:22414646
RGD:7243179
NCBI chr 6:158,004,545...158,046,428
Ensembl chr 6:163,014,663...163,054,681
G
SLC22A12
solute carrier family 22 member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14655203
NCBI chr11:59,944,311...59,956,102
Ensembl chr11:63,290,329...63,299,047
G
SLC22A2
solute carrier family 22 member 2
susceptibility treatment
ISO
mRNA:decreased expression:kidney DNA:SNP: :808G>T (rs316019) human
RGD
PMID:18612803 PMID:19625999 PMID:22414646
RGD:7243179 RGD:7243880 RGD:7243884
NCBI chr 6:158,058,226...158,150,917
Ensembl chr 6:163,065,317...163,158,931
G
SLC22A24
solute carrier family 22 member 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23649842 PMID:26230185
NCBI chr11:58,431,450...58,497,875
G
SLC34A1
solute carrier family 34 member 1
disease_progression
ISO
associated with Sepsis; protein:decreased expression:renal proximal tubule (mouse)
RGD
PMID:19729856
RGD:7242943
NCBI chr 5:172,685,862...172,700,440
Ensembl chr 5:179,748,492...179,762,975
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr21:18,029,831...18,037,526
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11274264 PMID:20623750 PMID:22863853
RGD:6903264
NCBI chr 4:80,263,711...80,271,466
Ensembl chr 4:90,988,200...90,995,935
G
TBX1
T-box transcription factor 1
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:24817956
RGD:155882498
NCBI chr22:2,521,080...2,541,267
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:130,799,063...130,830,227
Ensembl chr 3:138,274,159...138,305,476
G
TFF3
trefoil factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr21:28,627,191...28,631,341
Ensembl chr21:41,948,696...41,952,268
G
TGFA
transforming growth factor alpha
ISO
mRNA:increased expression:kidney
RGD
PMID:11340354
RGD:10395241
NCBI chr2A:70,510,727...70,617,628
Ensembl chr2A:71,625,196...71,731,461
G
TGFB1
transforming growth factor beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10469268
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TGFBR1
transforming growth factor beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34677723
NCBI chr 9:70,195,007...70,243,514
Ensembl chr 9:98,332,739...98,362,748
G
THBD
thrombomodulin
treatment
ISO
RGD
PMID:17804460 PMID:19176699
RGD:5684994 RGD:5685010
NCBI chr20:22,992,341...22,996,415
Ensembl chr20:23,345,917...23,347,812
G
TLR2
toll like receptor 2
ISO
associated with Sepsis CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22655058 PMID:29286200
RGD:7207898
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
treatment
ISO
associated with Sepsis CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16638912 PMID:22266601 PMID:22655058 PMID:29286200
RGD:6892690 RGD:7207898 RGD:7241084
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16595132 PMID:18460982 PMID:20623750 PMID:21150875
RGD:7245548
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF12A
TNF receptor superfamily member 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr16:1,962,179...1,964,223
Ensembl chr16:3,134,577...3,136,581
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
associated with Endotoxemia associated with Shock, Septic;protein:increased expression:serum associated with Acute Lung Injury
RGD
PMID:12023385 PMID:12500222 PMID:18074478 PMID:21150875
RGD:5128661 RGD:7245534 RGD:7245535 RGD:7245548
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
associated with Acute Lung Injury associated with Shock, Septic;protein:increased expression:serum
RGD
PMID:12500222 PMID:12865254 PMID:18074478
RGD:5128661 RGD:7245532 RGD:7245534
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20603111
NCBI chr17:7,699,449...7,717,812
Ensembl chr17:7,684,922...7,706,120
G
TTR
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr18:24,809,707...24,816,713
Ensembl chr18:28,407,893...28,414,960
G
UTS2R
urotensin 2 receptor
ISO
RGD
PMID:15146030
RGD:2306847
NCBI chr17:76,783,432...76,788,639
Ensembl chr17:82,592,312...82,593,702
G
VEGFA
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20943766 PMID:22808199
NCBI chr 6:43,361,053...43,377,366
Ensembl chr 6:44,650,365...44,666,353
G
WNT4
Wnt family member 4
ISO
RGD
PMID:12707392
RGD:727218
NCBI chr 1:21,310,228...21,335,985
Ensembl chr 1:22,255,056...22,268,801
G
XDH
xanthine dehydrogenase
treatment
ISO
associated with Reperfusion Injury
RGD
PMID:18539378 PMID:19628223 PMID:22571266
RGD:7247641 RGD:7247650 RGD:7247656
NCBI chr2A:31,356,011...31,435,111
Ensembl chr2A:31,425,183...31,504,455
G
ZNF644
zinc finger protein 644
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36052886
NCBI chr 1:93,573,781...93,686,786
Ensembl chr 1:92,322,540...92,348,120
G
AK4
adenylate kinase 4
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:21152904
RGD:5134352
NCBI chr 1:64,394,898...64,479,536
Ensembl chr 1:66,283,102...66,361,230
G
BMP7
bone morphogenetic protein 7
ISO
associated with Kidney Reperfusion Injury;protein:increased expression:kidney
RGD
PMID:16284088
RGD:1601494
NCBI chr20:53,509,484...53,606,889
Ensembl chr20:54,788,974...54,885,021
G
CCT7
chaperonin containing TCP1 subunit 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31825490
NCBI chr2A:73,287,026...73,305,792
Ensembl chr2A:74,775,781...74,794,515
G
CIITA
class II major histocompatibility complex transactivator
ISO
mRNA:increased expression:kidney
RGD
PMID:9422398
RGD:7242901
NCBI chr16:9,819,440...9,885,379
Ensembl chr16:11,041,434...11,090,485
G
FABP1
fatty acid binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18368030
NCBI chr2A:87,256,032...87,303,505
Ensembl chr2A:89,165,315...89,170,448
G
GSR
glutathione-disulfide reductase
ISO
protein:decreased activity:renal cortex:
RGD
PMID:12885594 PMID:17078987
RGD:7257555 RGD:7257573
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:kidney tubule, urine:
RGD
PMID:12081583
RGD:7245970
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
NOG
noggin
ISO
associated with Kidney Reperfusion Injury
RGD
PMID:16284088
RGD:1601494
NCBI chr17:50,669,186...50,671,081
Ensembl chr17:55,532,394...55,533,092
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:4358912 PMID:6254450
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19834340
Ensembl chr22:45,218,364...45,302,970
G
SOD2
superoxide dismutase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19917352
NCBI chr 6:157,562,814...157,610,155
Ensembl chr 6:162,576,082...162,589,960
G
TEK
TEK receptor tyrosine kinase
ISO
associated with Kidney Reperfusion Injury
RGD
PMID:16284088
RGD:1601494
NCBI chr 9:26,955,339...27,077,809
Ensembl chr 9:27,561,421...27,683,572
G
ACO1
aconitase 1
ISO
RGD
PMID:20176611
RGD:11541086
NCBI chr 9:32,157,763...32,225,116
Ensembl chr 9:32,967,993...33,035,177
G
ALB
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr 4:50,773,244...50,790,474
Ensembl chr 4:56,605,322...56,622,418
G
CCN2
cellular communication network factor 2
disease_progression
ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr 6:129,729,572...129,733,113
Ensembl chr 6:133,836,319...133,842,077
G
CLU
clusterin
treatment
ISO
RGD
PMID:22494435
RGD:9068431
NCBI chr 8:26,867,973...26,884,838
Ensembl chr 8:24,070,053...24,083,523
G
CS
citrate synthase
treatment
ISO
RGD
PMID:20005400
RGD:243048470
NCBI chr12:32,614,982...32,643,719
Ensembl chr12:32,867,225...32,895,854
G
MMP3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr11:97,776,729...97,784,549
Ensembl chr11:101,267,566...101,275,354
G
MMP7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:18209025
RGD:9685339
NCBI chr11:97,467,037...97,477,305
Ensembl chr11:100,960,032...100,971,099
G
PDGFA
platelet derived growth factor subunit A
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 7:648,722...672,023
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA:increased expression:kidney:
RGD
PMID:11889420 PMID:15785371
RGD:10449491 RGD:11080974
NCBI chr22:20,127,223...20,148,407
Ensembl chr22:37,944,018...37,964,883
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 4:69,639,081...69,709,870
Ensembl chr 4:76,199,382...76,271,097
G
PDGFRB
platelet derived growth factor receptor beta
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:145,538,330...145,580,312
Ensembl chr 5:151,543,891...151,585,530
G
PLAU
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr10:70,433,340...70,441,569
Ensembl chr10:73,105,895...73,113,136
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
SERPINE1
serpin family E member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 RGD:13208601
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CRP
C-reactive protein
ISO
associated with coronary disease;
RGD
PMID:23102387
RGD:6909166
NCBI chr 1:135,062,102...135,064,402
G
DDIT3
DNA damage inducible transcript 3
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr12:31,406,332...31,410,293
Ensembl chr12:31,664,743...31,668,701
G
ECE1
endothelin converting enzyme 1
ISO
mRNA,protein:increased expression:kidney medulla
RGD
PMID:18385664
RGD:7243946
NCBI chr 1:20,166,019...20,290,803
Ensembl chr 1:21,206,199...21,278,909
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:urine:
RGD
PMID:23335628
RGD:7245471
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
HSPA5
heat shock protein family A (Hsp70) member 5
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr 9:96,351,645...96,356,761
Ensembl chr 9:124,865,211...124,870,458
G
IL1B
interleukin 1 beta
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22094062
RGD:7175334
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
LCN2
lipocalin 2
ISO
associated with Diabetes Mellitus, Experimental; protein:increased expression:urine protein:increased expression:urine:
RGD
PMID:23085980 PMID:23335628
RGD:7245471 RGD:7245484
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
G
MAPK8
mitogen-activated protein kinase 8
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr10:45,806,748...45,936,362
G
MPO
myeloperoxidase
ISO
RGD
PMID:20722568
RGD:6909183
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
G
NPPA
natriuretic peptide A
ISO
RGD
PMID:19298916
RGD:7247719
NCBI chr 1:10,608,025...10,610,287
Ensembl chr 1:11,825,072...11,827,373
G
NPPB
natriuretic peptide B
ISO
associated with Heart Failure
RGD
PMID:20438292
RGD:7248591
NCBI chr 1:10,621,416...10,622,960
Ensembl chr 1:11,838,518...11,839,995
G
EDN1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7967349
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
G
HMOX1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21253390
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
SOD1
superoxide dismutase 1
ISO
RGD
PMID:15531919
RGD:1581228
NCBI chr21:18,029,831...18,037,526
G
TLR4
toll like receptor 4
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:18093430
RGD:4144102
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
ISO
protein:increased expression:plasma
RGD
PMID:18093430
RGD:4144102
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
ACE
angiotensin I converting enzyme
ISO
RGD
PMID:21680852
RGD:6893484
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
ACE2
angiotensin converting enzyme 2
ISO
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:8,189,267...8,229,415
Ensembl chr X:15,470,896...15,510,891
G
ACTA1
actin alpha 1, skeletal muscle
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:204,975,646...204,978,523
Ensembl chr 1:210,007,622...210,010,469
G
ACVR2B
activin A receptor type 2B
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 3:38,350,838...38,389,839
Ensembl chr 3:38,633,093...38,662,063
G
ADAM17
ADAM metallopeptidase domain 17
treatment
ISO
RGD
PMID:22015440
RGD:13703100
NCBI chr2A:9,478,080...9,545,363
Ensembl chr2A:9,641,201...9,708,054
G
ADAM2
ADAM metallopeptidase domain 2
ISO
RGD
PMID:11967014
RGD:10047130
NCBI chr 8:38,939,413...39,034,142
Ensembl chr 8:36,448,201...36,542,784
G
ADAMTS1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:18272597
RGD:9684850
NCBI chr21:13,270,668...13,279,217
Ensembl chr21:26,656,370...26,665,485
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr 3:183,876,051...183,889,723
Ensembl chr 3:192,341,320...192,354,885
G
ADM
adrenomedullin
treatment
ISO
protein:increased expression:serum:
RGD
PMID:20538296
RGD:7364948
NCBI chr11:10,437,712...10,440,053
Ensembl chr11:10,165,418...10,167,842
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO
RGD
PMID:31089212
RGD:27226686
NCBI chr 1:44,853,867...44,871,764
Ensembl chr 1:46,211,859...46,230,072
G
ALDH2
aldehyde dehydrogenase 2 family member
ISO
RGD
PMID:22022451
RGD:7241603
NCBI chr12:109,343,020...109,385,060
Ensembl chr12:112,734,243...112,776,471
G
ANXA1
annexin A1
treatment
ISO
RGD
PMID:20953576
RGD:7421585
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
ANXA5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 4:113,868,218...113,897,243
Ensembl chr 4:125,006,038...125,034,972
G
APAF1
apoptotic peptidase activating factor 1
treatment
ISO
RGD
PMID:26362957
RGD:13703110
NCBI chr12:96,224,515...96,311,246
Ensembl chr12:99,637,622...99,726,939
G
APOA1
apolipoprotein A1
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr11:111,673,539...111,675,428
Ensembl chr11:115,606,136...115,608,122
G
ATM
ATM serine/threonine kinase
ISO
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr11:103,109,979...103,256,405
Ensembl chr11:106,584,228...106,727,041
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:18221257 PMID:29285062
RGD:13792599 RGD:2293026
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
BDKRB1
bradykinin receptor B1
ISO
RGD
PMID:18725957
RGD:7241559
NCBI chr14:76,885,923...76,894,456
G
BECN1
beclin 1
treatment
ISO
RGD
PMID:26412257
RGD:11561958
NCBI chr17:14,493,619...14,507,809
Ensembl chr17:14,719,781...14,733,286
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr10:22,477,755...22,487,894
Ensembl chr10:22,857,776...22,863,479
G
BNIP3
BCL2 interacting protein 3
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr10:128,671,663...128,685,952
Ensembl chr10:132,858,211...132,871,634
G
C3
complement C3
treatment
ISO
RGD
PMID:19691975
RGD:7411689
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CALCA
calcitonin related polypeptide alpha
ISO
RGD
PMID:19194162
RGD:7204479
NCBI chr11:15,055,897...15,061,539
Ensembl chr11:14,745,588...14,751,267
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr 4:176,793,190...176,815,023
Ensembl chr 4:189,018,422...189,040,185
G
CASP7
caspase 7
ISO
RGD
PMID:17596683
RGD:5684536
NCBI chr10:110,273,318...110,324,800
Ensembl chr10:113,707,780...113,758,626
G
CCL2
C-C motif chemokine ligand 2
treatment ameliorates
ISO
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:18650485 PMID:20396927 PMID:24920753
RGD:11526113 RGD:329845564 RGD:4891433
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCN1
cellular communication network factor 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:118,138,739...118,141,681
Ensembl chr 1:86,994,296...86,997,147
G
CD14
CD14 molecule
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:25993320
RGD:11251055
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CFB
complement factor B
ISO
RGD
PMID:12538716 PMID:16467447
RGD:7242709 RGD:7242734
NCBI chr 6:31,606,716...31,612,782
G
CFH
complement factor H
treatment
ISO
protein:decreased expression:serum:
RGD
PMID:20538296
RGD:7364948
NCBI chr 1:172,155,882...172,251,632
Ensembl chr 1:176,455,247...176,525,521
G
CIITA
class II major histocompatibility complex transactivator
ISO
RGD
PMID:14569092
RGD:7242896
NCBI chr16:9,819,440...9,885,379
Ensembl chr16:11,041,434...11,090,485
G
CITED1
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:61,537,949...61,543,545
Ensembl chr X:71,621,785...71,625,702
G
COL1A1
collagen type I alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr17:44,274,349...44,291,764
Ensembl chr17:49,150,677...49,166,677
G
COL3A1
collagen type III alpha 1 chain
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr2B:76,285,115...76,322,703
Ensembl chr2B:194,204,613...194,242,956
G
CSF1
colony stimulating factor 1
ISO
mRNA:increased expression:kidney
RGD
PMID:19196448 PMID:23143303
RGD:7257565 RGD:7257570
NCBI chr 1:112,555,755...112,575,894
Ensembl chr 1:127,764,916...127,781,943
G
CSF1R
colony stimulating factor 1 receptor
ISO
RGD
PMID:23143303
RGD:7257565
NCBI chr 5:145,478,725...145,537,858
Ensembl chr 5:151,483,572...151,517,415
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
ISO
RGD
PMID:9407517 PMID:22189844
RGD:7204675 RGD:7204727
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:20038794
RGD:7257679
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr2B:23,744,271...23,748,106
Ensembl chr2B:140,181,829...140,189,647
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
treatment
ISO
RGD
PMID:23552495
RGD:7244372
NCBI chr15:30,152,924...30,282,854
Ensembl chr15:48,486,688...48,521,554
G
DAXX
death domain associated protein
ISO
protein:increased expression:kidney:
RGD
PMID:18480747
RGD:9587836
NCBI chr 6:32,890,846...32,895,307
Ensembl chr 6:34,004,543...34,008,717
G
DDR1
discoidin domain receptor tyrosine kinase 1
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr 6:30,625,871...30,645,066
Ensembl chr 6:31,496,047...31,513,455
G
DHFR
dihydrofolate reductase
treatment
ISO
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr 5:34,663,210...34,689,467
Ensembl chr 5:34,938,548...34,967,003
G
DRD3
dopamine receptor D3
treatment
ISO
RGD
PMID:25989500
RGD:13506961
NCBI chr 3:111,265,834...111,317,176
Ensembl chr 3:118,187,636...118,237,403
G
EED
embryonic ectoderm development
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr11:81,295,068...81,330,321
Ensembl chr11:84,902,330...84,937,906
G
EGLN1
egl-9 family hypoxia inducible factor 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 1:206,915,541...206,976,656
G
EGLN3
egl-9 family hypoxia inducible factor 3
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr14:14,689,398...14,716,301
Ensembl chr14:32,880,324...32,907,241
G
ELANE
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:16980042
RGD:10450580
NCBI chr19:276,499...280,598
G
ENG
endoglin
ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653
RGD:7248779
NCBI chr 9:98,934,080...98,973,862
Ensembl chr 9:127,605,608...127,644,641
G
EP300
E1A binding protein p300
ISO
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr22:21,986,467...22,076,921
Ensembl chr22:40,079,503...40,168,604
G
EPO
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 RGD:11041698
NCBI chr 7:92,747,671...92,750,886
Ensembl chr 7:106,148,062...106,150,974
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 7:140,536,962...140,613,104
Ensembl chr 7:153,017,590...153,059,726
G
F3
coagulation factor III, tissue factor
ISO
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 1:97,190,381...97,203,076
Ensembl chr 1:95,918,502...95,931,050
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
FCGR1A
Fc gamma receptor Ia
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 1:125,127,073...125,136,911
Ensembl chr 1:128,805,484...128,814,220
G
FGA
fibrinogen alpha chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 4:146,949,680...146,957,291
G
FGB
fibrinogen beta chain
treatment
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 4:146,929,561...146,937,665
Ensembl chr 4:158,747,659...158,755,766
G
FGFR2
fibroblast growth factor receptor 2
exacerbates ameliorates
ISO
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960
RGD:155663667 RGD:155782882 RGD:155782904 RGD:155882537
NCBI chr10:118,055,854...118,175,440
Ensembl chr10:121,469,735...121,588,815
G
FGG
fibrinogen gamma chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 4:146,970,671...146,979,348
Ensembl chr 4:158,788,966...158,797,237
G
FN1
fibronectin 1
ISO
RGD
PMID:11352844
RGD:7205629
NCBI chr2B:102,623,568...102,698,747
Ensembl chr2B:221,208,431...221,284,003
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
RGD
PMID:19095962
RGD:7242184
NCBI chr14:55,832,570...55,835,984
Ensembl chr14:74,676,316...74,679,766
G
GFER
growth factor, augmenter of liver regeneration
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:20332418
RGD:9685723
NCBI chr16:716,640...720,196
Ensembl chr16:2,073,064...2,076,592
G
GLO1
glyoxalase I
ISO
RGD
PMID:19211689
RGD:7242566
NCBI chr 6:38,247,881...38,275,098
Ensembl chr 6:39,434,746...39,461,971
G
GPX3
glutathione peroxidase 3
ISO
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:22442209 PMID:37033969
RGD:401827821 RGD:401827906
NCBI chr 5:146,447,939...146,456,476
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24630969
RGD:10401866
NCBI chr 8:29,990,543...30,040,157
Ensembl chr 8:27,180,300...27,229,557
G
GSTM1
glutathione S-transferase mu 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
Ensembl chr 1:127,979,238...128,010,411
G
HAS1
hyaluronan synthase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr19:48,657,165...48,668,130
Ensembl chr19:57,537,049...57,547,804
G
HAS2
hyaluronan synthase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 8:118,313,186...118,342,160
Ensembl chr 8:121,072,154...121,089,365
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:urine:
RGD
PMID:23019274 PMID:23085062 PMID:23552495
RGD:7244372 RGD:7245489 RGD:7245495
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
HIF1A
hypoxia inducible factor 1 subunit alpha
treatment severity
ISO
RGD
PMID:17519789 PMID:22432008
RGD:1626334 RGD:9068883
NCBI chr14:42,295,691...42,348,478
Ensembl chr14:60,552,374...60,604,885
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:21291499
RGD:10755580
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
HSF1
heat shock transcription factor 1
ISO
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr 8:141,055,310...141,078,360
Ensembl chr 8:144,062,137...144,067,866
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
RGD
PMID:7569112
RGD:7242788
NCBI chr11:117,890,545...117,895,262
Ensembl chr11:121,809,800...121,815,773
G
HYAL1
hyaluronidase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 3:50,228,491...50,238,798
Ensembl chr 3:51,463,239...51,467,286
G
HYAL2
hyaluronidase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 3:50,243,926...50,248,972
Ensembl chr 3:51,479,020...51,482,551
G
IFNG
interferon gamma
treatment
ISO
RGD
PMID:28355607
RGD:14975115
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IGF1R
insulin like growth factor 1 receptor
ISO
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr15:77,332,926...77,648,474
Ensembl chr15:96,535,164...96,832,974
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:19546526
RGD:7495779
NCBI chr 8:41,515,613...41,576,229
Ensembl chr 8:38,960,594...39,020,971
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:24079335 PMID:28664613
RGD:14975137 RGD:7364864
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL12B
interleukin 12B
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:154,706,467...154,722,231
Ensembl chr 5:161,325,303...161,335,381
G
IL18
interleukin 18
treatment
ISO
RGD
PMID:22089199
RGD:8655971
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ameliorates
ISO
RGD
PMID:20030532 PMID:24920753
RGD:329845564 RGD:7175501
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL1RN
interleukin 1 receptor antagonist
ISO
rat model treated with human protein mouse model treated with human protein
RGD
PMID:9555664 PMID:16849996 PMID:18363573
RGD:6907101 RGD:6907359 RGD:6909149
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
IL6
interleukin 6
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:23,415,922...23,420,767
G
INHBB
inhibin subunit beta B
ISO
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr2B:7,278,944...7,284,632
G
ITGB2
integrin subunit beta 2
ISO
Associated with renal transplant patients
RGD
PMID:11007822 PMID:20504838
RGD:6907049 RGD:6907073
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
G
KCNJ11
potassium inwardly rectifying channel subfamily J member 11
ISO
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr11:17,440,522...17,444,075
Ensembl chr11:17,127,557...17,128,729
G
KL
klotho
treatment
ISO
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278
RGD:10403064
NCBI chr13:14,272,463...14,321,122
Ensembl chr13:32,702,336...32,751,458
G
KMT2A
lysine methyltransferase 2A
ISO
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr11:113,273,198...113,364,404
Ensembl chr11:117,204,820...117,290,100
G
LCN2
lipocalin 2
ISO
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney:
RGD
PMID:20181666 PMID:23085062 PMID:23364806 PMID:27800610
RGD:126779563 RGD:126790572 RGD:7245469 RGD:7245489
NCBI chr 9:99,259,278...99,274,494
Ensembl chr 9:127,940,799...127,944,798
G
LEP
leptin
resistance
ISO
RGD
PMID:22969992
RGD:6909133
NCBI chr 7:120,230,896...120,248,602
Ensembl chr 7:132,885,011...132,901,519
G
LGALS3
galectin 3
ISO
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr14:35,715,850...35,732,263
Ensembl chr14:53,990,023...54,006,412
G
LOC100974886
uncharacterized LOC100974886
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 4:50,092,989...50,095,541
Ensembl chr 4:55,925,562...55,986,555
G
LOC100994157
histone H2AX
treatment
ISO
RGD
PMID:23726287
RGD:8693706
NCBI chr11:113,932,078...113,933,679
G
LOC103785028
polycomb protein SUZ12
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:24,790,921...24,853,790
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:20075199 PMID:26412257
RGD:11561916 RGD:11561958
NCBI chr20:30,887,345...30,888,986
Ensembl chr20:32,010,284...32,020,411
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:23952292
RGD:10412647
NCBI chr 6:134,316,841...134,582,843
Ensembl chr 6:138,406,398...138,641,727
G
MC1R
melanocortin 1 receptor
ISO
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr16:70,676,447...70,697,636
G
MPO
myeloperoxidase
ISO
protein:increased activity:kidney
RGD
PMID:18055546 PMID:22950848
RGD:6909167 RGD:7174699
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
G
MUC1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:22019164
RGD:7245959
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
G
MYC
MYC proto-oncogene, bHLH transcription factor
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr 8:124,387,561...124,393,551
Ensembl chr 8:127,131,512...127,136,863
G
NDUFB8
NADH:ubiquinone oxidoreductase subunit B8
ISO
RGD
PMID:22160772 PMID:24096033
RGD:13801197 RGD:13801199
NCBI chr10:97,123,826...97,129,919
Ensembl chr10:100,604,914...100,611,016
G
NES
nestin
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr 1:132,012,273...132,020,907
Ensembl chr 1:135,835,456...135,844,094
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:31089916
RGD:155882543
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
NOS2
nitric oxide synthase 2
treatment
ISO
RGD
PMID:18408363
RGD:11040540
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
NOS3
nitric oxide synthase 3
treatment
ISO
RGD
PMID:18408363 PMID:29291552
RGD:11040540 RGD:13504682
NCBI chr 7:142,577,334...142,600,702
Ensembl chr 7:154,730,009...154,755,233
G
NOX1
NADPH oxidase 1
treatment
ISO
RGD
PMID:34244746
RGD:329955363
NCBI chr X:90,046,023...90,076,968
Ensembl chr X:100,182,398...100,215,192
G
NPPA
natriuretic peptide A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 1:10,608,025...10,610,287
Ensembl chr 1:11,825,072...11,827,373
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:21545725
RGD:11035217
NCBI chr16:50,090,696...50,106,495
Ensembl chr16:69,470,288...69,489,731
G
NR4A1
nuclear receptor subfamily 4 group A member 1
severity
ISO
mRNA:increased expression:kidney
RGD
PMID:22343121
RGD:14700869
NCBI chr12:36,703,903...36,740,211
Ensembl chr12:37,480,300...37,501,188
G
OGG1
8-oxoguanine DNA glycosylase
ISO
RGD
PMID:12531391
RGD:2317150
NCBI chr 3:9,702,311...9,742,283
Ensembl chr 3:9,940,955...9,947,335
G
PAX2
paired box 2
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr10:97,344,978...97,429,086
Ensembl chr10:100,822,676...100,904,028
G
PDGFB
platelet derived growth factor subunit B
ISO
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr22:20,127,223...20,148,407
Ensembl chr22:37,944,018...37,964,883
G
PDGFRA
platelet derived growth factor receptor alpha
ISO
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr 4:69,639,081...69,709,870
Ensembl chr 4:76,199,382...76,271,097
G
PDGFRB
platelet derived growth factor receptor beta
ISO
mRNA:increased expression:kidney
RGD
PMID:10550325 PMID:12819032
RGD:1580850 RGD:8554477
NCBI chr 5:145,538,330...145,580,312
Ensembl chr 5:151,543,891...151,585,530
G
PEG10
paternally expressed 10
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 7:86,606,249...86,619,580
G
PKD2
polycystin 2, transient receptor potential cation channel
ISO
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr 4:80,295,243...80,365,271
Ensembl chr 4:91,019,734...91,086,775
G
PPARGC1A
PPARG coactivator 1 alpha
treatment
ISO
RGD
PMID:24918615
RGD:10059636
NCBI chr 4:18,196,431...18,876,889
Ensembl chr 4:23,483,377...23,581,212
G
PTGIS
prostaglandin I2 synthase
ISO
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr20:45,841,238...45,905,641
Ensembl chr20:46,905,665...46,971,612
G
RNLS
renalase, FAD dependent amine oxidase
ISO
RGD
PMID:23393318
RGD:7327166
NCBI chr10:84,996,999...85,304,240
Ensembl chr10:88,503,683...88,808,990
G
SERPINA1
serpin family A member 1
treatment
ISO
RGD
PMID:28235038
RGD:14695051
NCBI chr14:75,001,714...75,014,214
Ensembl chr14:94,334,258...94,345,419
G
SERPINC1
serpin family C member 1
severity
ISO
RGD
PMID:26108065
RGD:11354006
NCBI chr 1:149,421,737...149,435,301
Ensembl chr 1:153,126,031...153,139,369
G
SERPINE1
serpin family E member 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
SHH
sonic hedgehog signaling molecule
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 7:147,400,112...147,414,036
Ensembl chr 7:159,114,666...159,126,651
G
SIRT1
sirtuin 1
treatment
ISO
RGD
PMID:22324445
RGD:9495930
NCBI chr10:64,368,878...64,401,684
Ensembl chr10:66,681,598...66,715,069
G
SIX2
SIX homeobox 2
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr2A:45,109,414...45,113,887
Ensembl chr2A:46,039,582...46,044,035
G
SLC22A1
solute carrier family 22 member 1
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr 6:158,004,545...158,046,428
Ensembl chr 6:163,014,663...163,054,681
G
SLC22A2
solute carrier family 22 member 2
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr 6:158,058,226...158,150,917
Ensembl chr 6:163,065,317...163,158,931
G
SLC34A1
solute carrier family 34 member 1
ISO
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr 5:172,685,862...172,700,440
Ensembl chr 5:179,748,492...179,762,975
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
ISO
RGD
PMID:12819032
RGD:1580850
NCBI chr20:33,667,614...33,727,126
Ensembl chr20:34,822,271...34,839,634
G
STAT6
signal transducer and activator of transcription 6
severity
ISO
RGD
PMID:12709397
RGD:7244143
Ensembl chr12:32,068,679...32,085,099
G
TFPI
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr2B:74,744,154...74,834,338
Ensembl chr2B:192,541,881...192,581,384
G
TGFB1
transforming growth factor beta 1
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr19:38,324,009...38,347,003
Ensembl chr19:46,831,659...46,852,973
G
TLR2
toll like receptor 2
treatment severity
ISO
RGD
PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 PMID:23239000
RGD:7207892 RGD:7207894 RGD:7207896 RGD:7240552 RGD:7241087
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:11801667 PMID:20130923 PMID:23239000
RGD:7207892 RGD:7240552 RGD:7241087
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
ameliorates
ISO
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 RGD:329845564
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF1A
TNF receptor superfamily member 1A
ISO
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
G
VCAM1
vascular cell adhesion molecule 1
ISO
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 1:103,377,815...103,395,118
Ensembl chr 1:102,091,336...102,107,732
G
VWF
von Willebrand factor
ISO
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr12:6,073,836...6,249,806
Ensembl chr12:5,990,612...6,165,153
G
WT1
WT1 transcription factor
ISO
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr11:32,349,807...32,398,494
Ensembl chr11:32,238,720...32,287,249
G
XDH
xanthine dehydrogenase
treatment
ISO
associated with Diabetes Mellitus, Type 2
RGD
PMID:20616412 PMID:22995295
RGD:7247637 RGD:7247695
NCBI chr2A:31,356,011...31,435,111
Ensembl chr2A:31,425,183...31,504,455
G
ZNF667
zinc finger protein 667
ameliorates
ISO
RGD
PMID:24920753
RGD:329845564
NCBI chr19:53,465,103...53,502,535
Ensembl chr19:62,260,060...62,291,197
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all